Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
J Control Release. 2024 Mar;367:515-521. doi: 10.1016/j.jconrel.2024.01.027. Epub 2024 Feb 3.
This study explored the effectiveness of nasal administration in delivering magnetic nanoparticles into the brain for magnetic particle imaging of target regions. Successful delivery of iron oxide nanoparticles, which serve as contrast agents, to specific sites within the brain is crucial for achieving magnetic particle imaging. Nasal administration has gained attention as a method to bypass the blood-brain barrier and directly deliver therapeutics to the brain. In this study, we investigated surface modification techniques for administering magnetic nanoparticles into the nasal cavity, and provided experimental validation through in vivo studies. By compositing magnetic nanoparticles with gold nanoparticles, we enabled additional surface modification via AuS bonds without compromising their magnetic properties. The migration of the designed PEGylated magnetic nanoparticles into the brain following nasal administration was confirmed by magnetization measurements. Furthermore, we demonstrated the accumulation of these nanoparticles at specific target sites using probe molecules immobilized on the PEG terminus. Thus, the efficacy of delivering magnetic nanoparticles to the brain via nasal administration was demonstrated in this study. The findings of this research are expected to contribute significantly to the realization of magnetic particle imaging of target regions within the brain.
本研究探讨了经鼻腔给药将磁性纳米颗粒递送至大脑用于目标区域的磁粒子成像的效果。将氧化铁纳米颗粒(作为对比剂)成功递送至大脑内的特定部位对于实现磁粒子成像至关重要。经鼻腔给药作为一种绕过血脑屏障并将治疗药物直接递送至大脑的方法引起了关注。在这项研究中,我们研究了将磁性纳米颗粒递送至鼻腔的表面修饰技术,并通过体内研究提供了实验验证。通过将磁性纳米颗粒与金纳米颗粒复合,我们通过 AuS 键实现了额外的表面修饰,而不会影响其磁性。通过磁化测量证实了设计的聚乙二醇化磁性纳米颗粒经鼻腔给药后向大脑中的迁移。此外,我们通过固定在聚乙二醇末端的探针分子证明了这些纳米颗粒在特定靶部位的积累。因此,本研究证明了经鼻腔给药将磁性纳米颗粒递送至大脑的效果。这项研究的结果有望为实现大脑内目标区域的磁粒子成像做出重要贡献。
Naunyn Schmiedebergs Arch Pharmacol. 2025-4
Mater Sci Eng C Mater Biol Appl. 2016-3-6
Int J Nanomedicine. 2016-12-7
ACS Appl Mater Interfaces. 2025-7-2
Theranostics. 2024